Risk-based surveillance after surgical treatment of renal cell carcinoma

2018 ◽  
Vol 17 (2) ◽  
pp. e610
Author(s):  
P. Capogrosso ◽  
F. Muttin ◽  
A. Larcher ◽  
D. Sjoberg ◽  
E. Vertosick ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Jasper Decoene ◽  
Filip Ameye ◽  
Evelyne Lerut ◽  
Raymond Oyen ◽  
Hein Van Poppel ◽  
...  

Renal cell carcinomas (RCCs) are known for their unpredictable metastatic pattern. We present the case of a 63-year-old woman who initially presented in 1992 with a metastasis in the left calcaneus that led to the discovery of RCC. In 1998, a new metastasis was found in the ovary. In 2008, the diagnosis of a gallbladder metastasis was made. All metastases were surgically removed; no additional systemic therapies were used. Aggressive surgical treatment can prolong the survival of patients with resectable metastases. Patterns of metastasis are discussed, and a brief review of the literature is given regarding each localization.


2002 ◽  
Vol 41 (3) ◽  
pp. 262-266 ◽  
Author(s):  
N. Melissourgos ◽  
K. Doumas ◽  
I. Messini ◽  
E. Papaliodi ◽  
N.G. Kastrinakis ◽  
...  

2018 ◽  
Vol 26 (3) ◽  
pp. 385-390 ◽  
Author(s):  
Sebastian K Frees ◽  
Mohammed M Kamal ◽  
Sebastian Nestler ◽  
Patrick MF Levien ◽  
Samir Bidnur ◽  
...  

2018 ◽  
Vol 14 (2) ◽  
pp. 68-78 ◽  
Author(s):  
B. Ya. Alekseev ◽  
I. M. Shevchuk ◽  
A. D. Kaprin

Renal cell carcinoma (RCC) is one of the most common genitourinary malignancies worldwide. Approximately 25–30 % of newly diagnosed patients have metastatic RCC (mRCC), whereas in 20–30 % of cases, dissemination occurs after radical surgical treatment. The development of targeted and immunooncological agents in recent years significantly increased survival in patients with mRCC. However, clinicians faced a problem of choosing an optimal therapeutic regimen to achieve maximum effectiveness of the treatment. This article discusses the choice of second-line drugs for mRCC, advantages of axitinib and its optimal dosage, and efficacy of sunitinib depending on the disease prognosis.


2013 ◽  
pp. 235-394 ◽  
Author(s):  
John Reynard ◽  
Simon Brewster ◽  
Suzanne Biers

Basic pathology and molecular biology 236 Wilms’ tumour and neuroblastoma 238 Radiological assessment of renal masses 242 Benign renal masses 244 Renal cell carcinoma: pathology, staging, and prognosis 246 Renal cell carcinoma: epidemiology and aetiology 250 Renal cell carcinoma: presentation and investigation 252 Renal cell carcinoma (localized): surgical treatment I ...


2019 ◽  
Vol 18 (1) ◽  
pp. e1419-e1420
Author(s):  
P. Capogrosso ◽  
A. Larcher ◽  
F. Cianflone ◽  
F. Muttin ◽  
F. Trevisani ◽  
...  

2019 ◽  
Vol 23 (3) ◽  
pp. 240
Author(s):  
Juan Glinka ◽  
Rodrigo Sanchez Claria ◽  
Victoria Ardiles ◽  
Eduardo de Santibañes ◽  
Juan Pekolj ◽  
...  

2014 ◽  
Vol 96 (6) ◽  
pp. e18-e19 ◽  
Author(s):  
J George ◽  
K Grebenik ◽  
N Patel ◽  
D Cranston ◽  
S Westaby

The surgical treatment of advanced renal cancers is challenging. Renal cell carcinoma is interesting in that it invades the vasculature and can extend up as far as the right atrium. Extension of tumour thrombus into the right atrium represents level IV disease, according to Robson staging. Transoesophageal echocardiography is useful for diagnostic purposes. It is also of great value for intraoperative cardiac monitoring and to confirm the extent of vascular involvement.


Sign in / Sign up

Export Citation Format

Share Document